Aggressive pharmacological intervention using statins, ezetimibe, or PCSK9 inhibitors.
Virtually eliminates the mathematical probability of developing ASCVD by starving plaque formation.
Monitored via frequent bloodwork, operators titrate drugs to purposefully drive ApoB below 60 mg/dL.